M. Hayashi et al., The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells, HYPERTENS R, 23(5), 2000, pp. 521-525
It has been reported that calcium channel blockers (CCBs) have an inhibitor
y action on cell growth and transcriptional changes induced by cytokines an
d hormones, In this study, we examined the effects of CCBs on nuclear facto
r kappa B (NF kappa B), which plays a key role in the intracellular signali
ng of various growth factors and cytokines. The activity of NF kappa B was
determined by luciferase assay with the transfection of the reporter gene,
which has six NF kappa B-recognizing sequences in the upstream of herpes si
mplex Virus thymidine kinase promoter, In cultured human mesangial cells, i
ncreased intracellular calcium concentration by calcium ionophore, A23187,
showed a stimulatory effect on the phorbor 12-myristate 18-acetate (PMA)-in
duced activation of NF kappa B, while L-type calcium channel agonist, Bay K
8644, did not have any significant effects on either basal or PMA-stimulat
ed activity of NF kappa B, At a higher concentration (10 mu M), nifedipine,
verapamil, or efonidipine showed an inhibitory effect on the activation of
NF kappa B by PMA and A23187, while at a lower concentration (1 mu M), onl
y efonidipine showed a significant inhibitory effect. From these results, w
e conclude that CCBs have an inhibitory effect on NF kappa B via the indepe
ndent pathway of an L-type calcium channel and that the potency of this eff
ect is variable among L-type calcium channel blockers.